Catheter ablation versus anti-arrhythmic drug therapy for ventricular tachycardia in ischemic heart disease is the focus of this author response, which reports no new clinical findings.
Absolute Event Rate: 0% vs 0%
Francesco Santoro, MD, PhD, Laura Perrotta, MD, PhD, Giacomo Mugnai, MD, PhD; Response to the Letter Regarding “Catheter ablation vs. anti-arrhythmic drug
Santoro et al. (Mon,) reported a other. Catheter ablation versus anti-arrhythmic drug therapy for ventricular tachycardia in ischemic heart disease is the focus of this author response, which reports no new clinical findings.